IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity. - Wikidata - wikimedia - TriplyDB

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.

http://www.wikidata.org/entity/Q37052943

about

Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines Pathways and therapeutic targets in melanoma Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models Trial watch: Dendritic cell-based anticancer therapy Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy.microRNAs function in CD8+T cell biology Therapeutic cancer vaccines and combination immunotherapies involving vaccination The translation of cancer genomics: time for a revolution in clinical cancer care.Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive.Soluble mediators regulating immunity in early life Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.Optimizing dendritic cell-based approaches for cancer immunotherapy The relationship between blood IL-12p40 level and melanoma progression.Radiation Inhibits Interleukin-12 Production via Inhibition of C-Rel through the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Signaling Pathway in Dendritic Cells CD8(+) T-cell recognition of a synthetic epitope formed by t-butyl modification Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes.Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells.IL-1β, IL-8, and Matrix Metalloproteinases-1, -2, and -10 Are Enriched upon Monocyte-Breast Cancer Cell Cocultivation in a Matrigel-Based Three-Dimensional System.Glycyrrhiza uralensis water extract enhances dendritic cell maturation and antitumor efficacy of HPV dendritic cell-based vaccine.Immunogenicity is preferentially induced in sparse dendritic cell cultures.Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia.mRNA-based dendritic cell vaccines.Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.Dendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy.Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.Understanding dendritic cell immunotherapy in ovarian cancer.A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination.Dendritic Cells and Cancer Immunity.Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8(+) effector T cell responses.Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion.Comparative study of dendritic cells matured by using IL-1β, IL-6, TNF-α and prostaglandins E2 for different time span.mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma.Dendritic cell-based vaccines: Shining the spotlight on signal 3.λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine.Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells Insufficient interleukin-12 signalling favours differentiation of human CD4(+) and CD8(+) T cells into GATA-3(+) and GATA-3(+) T-bet(+) subsets in humanized mice.

P2860

Q26765345-6EDEDA4F-D4CA-4294-B89E-70BE437043A6 Q26772715-C2301F61-7F1F-4E78-B4CD-B0500A86931A Q26865736-B069FFAA-CC1D-4634-BF79-8831D870CE17 Q27012618-D454EABB-B966-4E10-972B-231FA15DDD10 Q27024047-796E18B9-51AF-4907-A9C3-ED4FED2C7FE8 Q27686800-722179AF-F12B-4554-B9B5-B76BC602C5B0 Q28082960-30E4D208-4BFC-4801-9AAD-CCE11E6D610E Q28397609-B0639FCE-F054-48AE-9A7C-F6648B1C2782 Q33772611-BE7BCA67-001E-4EC3-8785-BEFB84B065AC Q34113544-EFCC63B5-A673-4D16-B817-6D1B9E6D6B3C Q34238426-0C2B7DA2-26FE-4199-AAAF-035BAD043E75 Q34467270-C538F47B-5295-4EE1-B042-E2F60216D151 Q34637535-3AEB1AE4-2B8F-4BD7-8EB0-7B36A457DDD6 Q35071193-92901BAF-2A59-4C50-81E5-4511FB628988 Q35888942-A971EFCA-F37E-4C3D-84B9-0C049CF41337 Q36019759-864462CF-275C-4F67-8777-CBADFA87B058 Q36087538-65D7DB9A-A70B-4DCA-8AF9-627D176711EE Q36170378-39A4BE7D-10E8-4B49-B51C-9D5F0E1215EB Q36745227-C80D7F2F-C5DA-42EB-9D25-1DF6E70782D6 Q37685419-0537B984-08E7-4DC8-8770-ECF59CE85F3B Q37686631-6BF12581-AAAF-4165-8AB6-2D5A71E70FBE Q37690509-FE8898E1-5CF5-4CF6-8DF5-542544FA5844 Q38199545-F532B4DA-BFD0-4C5B-A7F8-C6D76A1CC3B3 Q38245928-B6153E6B-94C0-4FE9-B15E-187C2D1C48B8 Q38246769-67BB378B-9E01-447C-A010-7A30AA98B2B2 Q38389321-0C34261C-04F6-424F-BCD4-7CC01C4B30C7 Q38453644-4BB62A3B-22C3-4CFE-AC60-7ED27601E248 Q38672403-D89F1577-2D1F-442A-8274-F41C68BC9416 Q38808249-E6BF35E8-1726-4912-B6D6-D195084CBC53 Q38832639-0435012E-0E07-4C29-8AEF-93B40CBE9959 Q38994017-8B2EE779-001E-4A11-9ABF-730A76616D3A Q39243064-5ACB0904-74A9-488B-9C88-61C83E0DD0CC Q39546506-030A0F8C-991B-41E0-AE27-339F3A12247F Q40041237-DCC1392C-C3B2-40E5-BCDB-0010A8322321 Q40092538-A08FA553-5E98-4006-96DA-8C8DFCFA2EA7 Q41297982-ADF010C1-1AB4-4068-AE20-9F4CC6ACA698 Q41852244-AD8231A7-6FD5-4BAA-9B37-CD67B5E37DDD Q41853661-87A42CCA-FF26-4391-9273-6769CAB9AE87 Q41916556-DE6DF5D0-25FF-4F6B-A4EB-D1FAA7805ED4 Q42217868-3E4B6706-C299-4628-BAE9-C39DFBC30078

P2860

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.

http://www.wikidata.org/entity/Q37052943

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.

@en

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.

@nl

type

label

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.

@en

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.

@nl

prefLabel

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.

@en

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.

@nl

P1433

Q37052943-D0E2688C-5FEC-4294-BB84-D49C525B3B5E

P1476

Q37052943-1810978F-453E-4519-B9FB-26031B0368FE

P2093

Q37052943-037D8295-AFA3-426F-B241-2A0AD281B7E3

Q37052943-2982787F-2A95-471B-A2F9-4E64ACD6FDED

Q37052943-6707E1B7-A6E4-463A-8B89-0A3C7BDDC90C

Q37052943-7625BDC9-41C6-4477-ABBC-6C9C543A58A1

Q37052943-8047A30D-E10B-46B2-BCBE-4B5678B86694

Q37052943-834EE6C8-4B67-4441-9A3E-79A69F207A67

Q37052943-A59DEDD8-D925-4BF1-BAA4-B4ACDB162266

Q37052943-AF9F5F1B-E276-44C6-96AD-E037F2D76013

Q37052943-B3DAE581-C538-47F0-8840-DACB0E9048C0

Q37052943-FADA2F08-A525-4FA9-8B07-E0D8BC3F4498

P2860

Q37052943-049988C5-3223-44E2-848E-C23C79C06A3E

Q37052943-0A379D5F-43C6-462B-B9C5-397BAE4F1DE6

Q37052943-0FADF1EB-66E5-40CC-9044-D483F0D702B6

Q37052943-117B012B-7464-44B3-9903-850522F11887

Q37052943-1572F2C7-A089-4B14-9387-DEBF18296684

Q37052943-17AB2D58-0EE5-43DD-AF8C-978DDE7F23B4

Q37052943-1D537E5D-9D32-4EC6-AF20-A9D9E8E702AB

Q37052943-22CBBAE1-F3B1-4D9A-B051-E0D736BCB7CD

Q37052943-267013B1-2C94-4D0F-96E8-C178287FF04B

Q37052943-29320A9D-C9AC-4072-A086-D054262AD022

P304

Q37052943-D8975FF7-6F07-4144-AFF2-A222CFD24ECC

P31

Q37052943-39DA05EC-A146-4D3D-99A7-1887F3380A63

P356

Q37052943-BBDC37B6-5E5F-48B6-95E4-600C8427F862

P407

Q37052943-F37C9CD8-0291-47EF-AE35-A9E7E89750A8

P433

Q37052943-5BB36245-D929-48CF-BFEF-80EB666DCA76

P478

Q37052943-4903F932-30A9-425E-88D0-5C0AEA0CAF03

P577

Q37052943-786D2C58-F4A7-4B5F-8253-1F334D3B17B5

P698

Q37052943-8868FCAC-ABBC-423C-AF5A-8B4FE346CA23

P921

Q37052943-F4645BF7-850B-4737-B7DD-0FDB4AB14954

P932

Q37052943-BAAE7938-BAF1-49F4-AA84-4033F1AA1B8D

P356

P1433

Journal of Clinical Investigation

P1476

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.

@en

P2093

Alexander Huang

http://www.w3.org/2001/XMLSchema#string

Amer Alyasiry

http://www.w3.org/2001/XMLSchema#string

Beatriz M Carreno

http://www.w3.org/2001/XMLSchema#string

Gerald P Linette

http://www.w3.org/2001/XMLSchema#string

Kathryn M Trinkaus

http://www.w3.org/2001/XMLSchema#string

Lynn A Cornelius

http://www.w3.org/2001/XMLSchema#string

Megan Chan

http://www.w3.org/2001/XMLSchema#string

Michelle Becker-Hapak

http://www.w3.org/2001/XMLSchema#string

Rebecca L Aft

http://www.w3.org/2001/XMLSchema#string

Wen-Rong Lie

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit

Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Coordinated regulation of myeloid cells by tumours

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

Interleukin-12 and the regulation of innate resistance and adaptive immunity

Taking dendritic cells into medicine

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

The immune contexture in human tumours: impact on clinical outcome

Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100.

P304

3383-3394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI68395

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23867552

http://www.w3.org/2001/XMLSchema#string

P921

P932

3726168

http://www.w3.org/2001/XMLSchema#string